Three new publications in the high impact JAMA group of journals provide information that could shape the way in which patients with a genetic predisposition are screened for cancers associated with brain and nerve cell tumours, Lynch Syndrome and Li-Fraumeni Syndrome.
The BRC has been busy this summer conducting scoping work to inform an ambitious, five year patient and public involvement and engagement (PPIE) strategy. Delivering exemplary PPIE across Greater Manchester, the strategy will serve both the BRC and the NIHR Manchester CRF.
The NIHR Manchester BRC and CRF launch event on 6 June 2017 represented a double celebration. An opportunity to share our aspirations for BRC and CRF, and also to mark the first anniversary of the GMHSCP devolution of the city region’s £6bn health and social care budget.
The Public Programmes Team, which leads on PPIE within the BRC and CRF, has secured a five year award from the Wellcome Trust Sustaining Excellence grant scheme following a rigorous and by invitation only review process.
At the beginning of April BRC researchers presented and exhibited at the business of precision medicine – visioning the future event in Leeds, jointly organised by the NHSA and BioNow.
Manchester Molecular Pathology Innovation Centre is holding the second of its exciting industry workshops on Thursday 8th June 10.00am- 4.00pm
Manchester researchers achieved peer recognition for their approach to cancer prevention and early diagnosis (PED), at a recent Cancer Research UK conference.
Opportunities to apply for NIHR Manchester Biomedical Research Centre PhD studentships, starting from September.